Non-germline genetically engineered mouse models for translational cancer research.
about
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphomaFrom human genome to cancer genome: the first decadeEmerging patterns of somatic mutations in cancerAnimal models of leukemia: any closer to the real thing?Preclinical validation of interleukin 6 as a therapeutic target in multiple myelomaPreclinical mouse cancer models: a maze of opportunities and challenges.Genetically engineered mouse models in oncology research and cancer medicineSpecies differences in tumour responses to cancer chemotherapyCross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.Making sense of cancer genomic data.Optimizing mouse models for precision cancer prevention.Applications of the CRISPR-Cas9 system in cancer biology.Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.Long non-coding RNAs in cancer and development: where do we go from here?Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene deliveryChoosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer.Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.Mouse models of advanced spontaneous metastasis for experimental therapeutics.Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal modelsLife in the fast lane: mammalian disease models in the genomics era.Effect of mutation order on myeloproliferative neoplasms.Creating anatomically accurate and reproducible intracranial xenografts of human brain tumorsToward personalized cancer nanomedicine - past, present, and future.Animal models of skin disease for drug discovery.Genetically engineered mouse models of pancreatic cancer.Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.Nanoparticle characterization: state of the art, challenges, and emerging technologies.Illuminating cancer systems with genetically engineered mouse models and coupled luciferase reporters in vivoThe clinical relevance of cancer cell lines.In vivo screening of S100B inhibitors for melanoma therapy.Somatic PIK3CA mutations as a driver of sporadic venous malformations.Omics and therapy - a basis for precision medicine.Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.Primary peritoneal carcinoma metastasizing to breast: a single case report and literature review from clinic to biology.A modular and flexible ESC-based mouse model of pancreatic cancer.BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim inductionMouse models of medulloblastoma.The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.Paediatric and adult malignant glioma: close relatives or distant cousins?
P2860
Q24294856-EC459156-468D-4B5C-BCC1-CD7A00E1DBDEQ26827640-73832269-9D97-4835-9D1B-F9B0CF7417A8Q27014126-E1C5A087-97BA-41AC-A2C1-F40838A44F99Q27026520-0A755BEB-4053-4A68-A312-57CC9470B45AQ27027729-B17DD255-1975-43A8-8265-3BDC483E920FQ27322080-075FB9E2-B4BB-42F0-A791-A35F72E98B32Q28079323-E0100BB2-DD1E-4D51-AE24-E02F4FC21845Q28080727-12CE09EB-6CE1-4B43-BD48-D64E489B0CACQ33677196-87A098BC-35EB-478F-9FC7-1C62E041654DQ33846850-9982D216-D7AC-4CDD-B409-A16E564A6339Q33919192-64E6E943-EE21-4F2C-8E91-CBC39445EF27Q34479139-4B7965CF-C1FA-4108-8933-53EB51B449AFQ34581396-7E11F601-C8C1-4860-B2BB-D6615AEDE64DQ34652500-BC7DBD28-8D3B-4C3C-9273-CBC8E3A40AF5Q35016600-25646C81-A079-435A-B1A9-C55AAD1BAF1BQ35148115-E0DF552B-B129-4486-AE9F-AE54447567DFQ35234634-D93B4C05-2452-47A7-AD56-690B741F2FDAQ35783079-63A542E0-5836-481F-8BE8-D6A9741143CAQ35966786-F0D4AE6C-B23D-41A3-BA09-F259C75EAB55Q36070093-AB48CE10-6EF3-4DE6-B157-BB164608D483Q36135110-271E575E-CFA0-41C2-BD5A-F2175F53053AQ36320344-84C701D1-7903-4918-8EA1-7ED1336448B0Q36412837-97BFF401-AE3B-4A62-8AF1-074CE359EFEBQ36472802-8D1CEAE1-DD79-4F45-BA06-A055D66145FFQ36631641-9064F254-8981-4BBB-8552-9F7955315F81Q36675786-6383748C-31BA-4DC1-98CE-155AD56ABF69Q36876967-E93CFD5E-9C2E-49F6-93D3-8F5FD62BAA8DQ36901928-1602711F-5622-498F-9EE1-7E398809C562Q36920226-346EB79E-5F7A-4D5B-93C2-14572C1EF34CQ36953572-9CB8257F-D75F-478D-96CA-F289C26069A9Q37033010-65F34070-9056-41D7-B855-C2876C09BDAEQ37130685-16ECEC96-1159-42FF-B83D-786454D0A98DQ37188017-07A26E41-0855-420E-8133-FC614389F764Q37277324-2121359A-0327-47EB-B356-B5D40D7AA162Q37349409-89BF97A8-C4CF-4B7F-8D37-5F916BBFC872Q37488746-7BF61D68-5C66-4665-93A5-7ACD5E515616Q37523017-E85FECFC-ACDC-4B88-83AF-114F564727D7Q37896219-04B9BFD7-CB92-4ECB-95C8-04FD9B5AF717Q37987661-76E4C92B-A59A-4332-98F1-4F3D0CEA771EQ38013990-01FB3FCF-6013-4740-A55A-243928ED7F4C
P2860
Non-germline genetically engineered mouse models for translational cancer research.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Non-germline genetically engineered mouse models for translational cancer research.
@ast
Non-germline genetically engineered mouse models for translational cancer research.
@en
type
label
Non-germline genetically engineered mouse models for translational cancer research.
@ast
Non-germline genetically engineered mouse models for translational cancer research.
@en
prefLabel
Non-germline genetically engineered mouse models for translational cancer research.
@ast
Non-germline genetically engineered mouse models for translational cancer research.
@en
P2093
P2860
P356
P1476
Non-germline genetically engineered mouse models for translational cancer research.
@en
P2093
Joerg Heyer
Lawrence N Kwong
Scott W Lowe
P2860
P2888
P304
P356
10.1038/NRC2877
P407
P50
P577
2010-07-01T00:00:00Z